Today's health news spans psychiatric medication breakthroughs, anatomical research gaps, advanced cancer treatments, infectious disease crises, and long-term wellness impacts, reflecting diverse progress and challenges across medicine.

Paroxetine shows clinical promise for refractory erythematous rosacea treatment, with a study revealing distinct proteomic changes in affected women, suggesting potential new therapeutic pathways for this difficult-to-treat skin condition.

Mapping the clitoris anatomy emerges as critical for women's health, with medical researchers identifying that decades of anatomical neglect has hindered understanding of postpartum nerve damage and chronic pelvic pain causes.

Dupilumab demonstrates superior efficacy compared to omalizumab in treating high-biomarker asthma patients, particularly those with concurrent chronic rhinosinusitis and nasal polyps, based on eosinophil and nitric oxide markers.

Congo's Ebola response faces critical strain one month after WHO's emergency declaration, with severe shortages in personnel to identify cases, ambulances for transport, and other essential outbreak containment resources.

Cannabis-associated psychosis exhibits distinct cognitive and behavioral patterns compared to non-cannabis psychosis, suggesting different underlying mechanisms that may require tailored treatment approaches.

Pembrolizumab monotherapy shows advantages over chemotherapy in non-small cell lung cancer treatment when considering broader pulmonary adverse effects beyond interstitial pneumonitis, offering safer immunotherapy options.

Blood transfusion has evolved into high-precision medicine where rigorous matching, testing, and tracing of every unit ensures dramatically improved safety standards compared to historical practices.

Midlife sleep problems correlate with diminished psychological well-being nearly a decade later, with women showing greater vulnerability than men, highlighting the long-term health consequences of sleep deprivation.